Liraglutide-associated acute pancreatitis

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Emily KnezevichAndjela Drincic

Abstract

A case of acute pancreatitis associated with liraglutide is reported. A 53-year-old African-American man (height, 185.4 cm; weight, 108.6 kg) with type 2 diabetes mellitus arrived at the emergency department (ED) with new-onset intolerable abdominal pain in the right upper quadrant and left upper quadrant that had appeared suddenly and lasted two to three hours. He had nausea but no vomiting, with tenderness in the epigastric region. In the ED, his serum amylase concentration was found to be extremely elevated (3,963 units/L), as was his serum lipase concentration (>15,000 units/L). In addition to type 2 diabetes, his medical history included hyperlipidemia, hypertension, peripheral neuropathy, erectile dysfunction, and obesity. His home medications included aspirin 81 mg orally daily, metformin 1000 mg orally every morning and 1500 mg every evening, simvastatin 80 mg orally daily at bedtime, tadalafil 20 mg orally as needed, glimepiride 4 mg orally twice daily, and liraglutide 1.2 mg subcutaneously daily. Two months before his arrival to the ED, the patient's dosage of liraglutide was increased from 0.6 to 1.2 mg subcutaneously daily. Radiographic data were obtained, and acute pancreatitis was diagnosed. Liraglutide was discon...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Sep 2, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Anil R Balani, James H Grendell
Aug 19, 2009·Diabetologia·D Russell-JonesUNKNOWN Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group
Oct 28, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardStanley S Schwartz
Apr 8, 2010·The Annals of Pharmacotherapy·Sarah L Anderson, Jennifer M Trujillo
Apr 24, 2010·International Journal of Clinical Practice·S S EngelB J Goldstein
Oct 19, 2010·International Journal of Clinical Practice. Supplement·G E Peterson, R D Pollom
Apr 14, 2011·The Annals of Pharmacotherapy·Phillip H LeeAndrea S Franks

❮ Previous
Next ❯

Citations

Aug 1, 2012·Diabetes Technology & Therapeutics·Krystal L EdwardsBrian K Irons
Jun 26, 2012·Expert Opinion on Pharmacotherapy·Eduard Montanya
Mar 20, 2013·Medicina clínica·Ana ArteroJosé T Real
Jan 11, 2016·Aging Clinical and Experimental Research·Simone PernaMariangela Rondanelli
Sep 24, 2014·Reproductive Biomedicine Online·Paula FontouraCristiane Fonte Ramos
Mar 3, 2015·Aging Clinical and Experimental Research·Hakan KorkmazErsin Akarsu
Jul 31, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tiffany Schwasinger-SchmidtLisa Stehno-Bittel
Dec 20, 2012·Thérapie·Hayet BourezaneJean-Pierre Kantelip
Nov 9, 2012·The Annals of Pharmacotherapy·Andrea S FranksChrista M George
Jan 17, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Adriane B MarinoDonald S Nuzum
Nov 20, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Anne Ottney
Sep 1, 2019·International Journal of Toxicology·Iku NiinomiKazunori Iwanaga
Nov 13, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Taichi NakamuraRyoichi Takayanagi
Jun 27, 2020·World Journal of Gastroenterology : WJG·Simcha WeissmanJames H Tabibian
Apr 7, 2021·Diabetes & Metabolic Syndrome·Marvin Wei Jie Chua, Yi Kang Ng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.